The board of directors of the company resolved to request the shareholders to authorize the board of directors to handle cash-increase of common shares to issue overseas depository receipts

The board of directors of the company resolved to request the shareholders to authorize the board of directors to handle private placement of common shares at the Annual General Meeting
May 11, 2018
Amendment on the announcement for 2018 Annual General Meeting (discussion notes)
May 16, 2018
  1. Date of the board of directors resolution: May 11, 2018
  2. Source of capital increase funds: ash-increase of common shares to issue overseas depository receipts
  3. Number of shares issued: no more than 15,000,000 shares
  4. Par value per share: NT$10
  5. Total monetary amount of the issue: To be determined
  6. Issue price: To be determined
  7. Number of shares subscribed by or allotted to employees: To be determined
  8. Number of shares publicly sold: To be determined
  9. Ratio of shares subscribed by or allotted as stock dividends to existing shareholders: To be determined
  10. Method of handling fractional shares and shares unsubscribed by the deadline: To be determined
  11. Rights and obligations of the newly issued shares: same as existing common shares
  12. Utilization of the funds from the capital increase: enrich working capital to support new drug research and development
  13. Any other matters that need to be specified: the case will be raised in the 2018 Annual General Meeting